- Abeona Therapeutics press release (NASDAQ:ABEO): FY GAAP EPS of -$1.55 beats by $0.21.
-
Cash, cash equivalents, short-term investments and restricted cash totaled $98.1 million as of December 31, 2024, compared to $52.6 million as of December 31, 2023.
-
Abeona estimates
Abeona Therapeutics GAAP EPS of -$1.55 beats by $0.21 (NASDAQ:ABEO)
